Analysis News
In-depth stock market analysis, technical indicators, and investment commentary. Expert insights on market trends, valuations, and trading strategies.
Recursion Pharmaceuticals Hits New Low Amid Revenue Drop and FDA Watch
Recursion Pharmaceuticals shares fell to a 52-week low Tuesday after Q1 revenue dropped 56% year-over-year. The AI-driven biotech firm awaits FDA feedback on key trials.
BofA Turns Bearish on Salesforce, Flags AI Risk to Growth Model
BofA Securities reinstated Salesforce with an Underperform rating and $160 target, citing AI risks to its growth model. Shares rose despite the bearish note.
SoFi Technologies Faces Pivotal Week After Volatile Friday Close
SoFi Technologies shares slipped 2.56% to $15.61 on Friday, entering a crucial week as the company prepares to present at J.P. Morgan's tech conference.
P&G's 70-Year Dividend Streak Faces Analyst Scrutiny Amid Cost Headwinds
P&G raised its dividend for the 70th consecutive year, but Wall Street remains cautious on cost pressures and tariff risks.
BigBear.ai Shares Dip 5% as Defense AI Optimism Fades
BigBear.ai shares dropped 5% to $4.16 after flat Q1 revenue and a wider loss, despite a 14% backlog increase driven by a $53 million classified contract.
SELLAS Stock Surges as REGAL Trial Nears Final Analysis
SELLAS Life Sciences shares rose after hours as its REGAL leukemia trial recorded 78 of 80 events needed for final analysis. The company reported a Q1 net loss of $8.4 million but has $107.1 million in cash.
Realty Income's New 150M Share Plan: A Strategic Shift in Capital Structure
Realty Income's new ATM program for up to 150 million shares could dilute existing holders by 16% as it seeks to fund a raised $9.5 billion investment plan for 2026.
NANO Nuclear's AI Data Center Deal Faces Reality Check on May 14
NANO Nuclear Energy stock surged on a Super Micro AI data center pact, but the non-binding MOU and pending NRC licensing leave investors waiting for real progress in the May 14 earnings update.